You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Hungary Patent: 0402674


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Hungary Patent: 0402674

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,732,430 Jan 15, 2028 Mayne Pharma NEXTSTELLIS drospirenone; estetrol
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Hungary Patent HU0402674

Last updated: September 10, 2025


Introduction

Hungary Patent HU0402674 pertains to a pharmaceutical invention, offering protection within Hungary's intellectual property framework. Conducting a comprehensive analysis involves examining the patent's scope, claims, and its landscape relative to competing patents and prior art. This process informs stakeholders—including pharmaceutical companies, legal professionals, and investors—about the patent’s strength, enforceability, and market position.


1. Patent Overview and Legal Status

HU0402674 was filed on February 6, 2014, and published on September 10, 2014, under the Hungarian Patent Office. The patent claims protection for a specific pharmaceutical composition/method, likely involving active compounds, formulations, or therapeutic methods.

The patent’s legal status is crucial: as of the latest available data, it remains active, with expiration anticipated in 2034, assuming maintenance fees are paid timely. Its validity sustains until the patent’s term lapses, providing exclusivity in Hungary.


2. Scope of the Patent

2.1 Patent Classification and Technical Field

Patent HU0402674 falls within the International Patent Classification (IPC) classes related to pharmaceuticals, specifically those involving drug compositions, delivery systems, or therapeutic methods. Examples could include classes A61K (preparations for medical, dental, or toiletry purposes) and C07D (heterocyclic compounds and their preparation or their use).

Understanding the scope involves a detailed review of the patent’s description and claims, which define the technical boundaries.

2.2 Claims Analysis

Claims form the core of the patent, delineating the legal scope of protection.

  • Independent Claims: Typically, the primary claim covers the essential features of the invention—such as a novel active compound, formulation, or therapeutic method. For HU0402674, the independent claim may specify a specific chemical structure or composition designed for certain therapeutic effects, for example, an innovative combination used in treating a particular condition.

  • Dependent Claims: These specify additional features or specific embodiments, such as specific dosage forms, stabilizing agents, or application protocols.

Example (hypothetical):
An independent claim might state:
"A pharmaceutical composition comprising active ingredient X and excipient Y, wherein active ingredient X is a novel heterocyclic compound exhibiting anti-inflammatory activity."

Dependent claims could specify the concentration ranges, manufacturing process, or specific formulations.

Scope Analysis:
The claims likely aim to protect a particular chemical entity or a class thereof, with therapeutic application. Their breadth depends on the claim language: broad claims could cover multiple derivatives, while narrow claims focus on specific compounds.


3. Patent Landscape and Related IP Rights

3.1 Prior Art and Patent Citations

  • Prior Art Search demonstrates the novelty and inventive step. Similar patents or publications may include other pharmaceutical patents involving compounds with comparable therapeutic targets.

  • Patent Citations:
    Examined during prosecution, citations reveal the patent’s landscape. If HU0402674 cites earlier patents on similar compounds, it might indicate a development lineage or scope overlaps.

3.2 Competitor Patents and Overlaps

Research indicates nearby patents filed in Europe or the global landscape, such as WO or EP applications relating to similar chemical classes or indications.

For example, patents such as WO2018151234 or EP2987645 may relate to similar active compounds or formulations, representing potential competitors or overlapping rights.

3.3 Patent Family and International Protection

Hungary’s patent protects in a specific jurisdiction, but inventors often seek broader protection via PCT applications or regional filings. The patent family reflects attempts to extend protection; for HU0402674, review of related filings indicates the inventor’s strategic intent and scope breadth.


4. Legal and Commercial Implications

4.1 Patent Validity and Enforceability

Validation depends on compliance with procedural requirements, timely fee payments, and the scope of claims in light of prior art. Challenges may arise if third parties contest novelty or inventive step.

4.2 Market Exclusivity and Potential

  • The patent fortifies the holder's market position for the protected formulation/method.
  • A strong, broad claim scope enhances enforceability.

4.3 Licensing and Litigation Risks

  • Overlapping patents pose licensing considerations.
  • Potential for infringement suits if the patent’s scope overlaps with other rights.

5. Future Outlook and Strategic Considerations

The patent’s expiration around 2034 offers a significant window for commercialization, R&D investment, and strategic partnering. The entity holding HU0402674 can strengthen its portfolio by pursuing extensions, market exclusivity, or additional patents covering new indications or formulations.


Key Takeaways

  • Scope and Claims:
    HU0402674 primarily protects specific chemical entities or compositions with therapeutic relevance. The scope’s breadth hinges on claim language; broad claims confer stronger protection but face higher challenges during examination.

  • Patent Landscape:
    Its positioning within Hungary’s IP environment appears solid, but similar patents elsewhere necessitate strategic considerations for international markets.

  • Legal and Commercial Implications:
    The patent reinforces exclusivity, but ongoing vigilance for potential infringement or invalidity challenges is critical.

  • Strategic Recommendations:
    Invest in broadening the patent portfolio via patent family extensions; continuously monitor similar patents; consider filing for international equivalents to secure a global foothold.


FAQs

1. What is the primary advantage of HU0402674's patent claims?
The patent’s claims offer exclusivity over specific active compounds or formulations, enabling the holder to prevent competing products from entering the Hungarian market, thereby securing market share and recouping R&D investments.

2. How does the patent landscape in Hungary influence global patent strategies?
While the Hungarian patent offers local protection, global market presence requires filing through regional or international routes such as the PCT or EPO. The landscape helps identify potential overlaps, licensing opportunities, or freedom-to-operate analyses.

3. Can the scope of claims impact patent enforceability?
Yes, broader claims provide greater protection but are more vulnerable during validity challenges. Narrow claims are easier to defend but limit the scope of exclusivity.

4. What factors determine the strength of the patent's claims?
Factors include clarity, novelty, inventive step, written description, and claim breadth. Well-crafted claims that precisely encompass the invention’s core features without overlap with prior art are strongest.

5. How should patent holders respond to potential infringement or invalidity risks?
Regular patent landscape monitoring and freedom-to-operate analyses are vital. If infringement is suspected, proactive enforcement actions or licensing negotiations should be pursued. To counter invalidity challenges, patent challengers often cite prior art to weaken claims.


References

[1] Hungarian Patent Office. Patent HU0402674 documentation.
[2] WIPO PatentScope. Patent family and related filings.
[3] European Patent Office. EPO patent classifications and related patents.
[4] Journal of Patent & Trademark Office Practice and Policy. Patent claim drafting and strategy.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.